Dnca Finance lowered its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 9.6% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 52,000 shares of the conglomerate’s stock after selling 5,500 shares during the period. Dnca Finance’s holdings in Danaher were worth $10,272,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the company. Red Tortoise LLC grew its stake in shares of Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after purchasing an additional 98 shares during the last quarter. Ramirez Asset Management Inc. purchased a new stake in Danaher in the 2nd quarter worth approximately $40,000. Twin Peaks Wealth Advisors LLC bought a new stake in shares of Danaher in the 2nd quarter worth approximately $51,000. Strengthening Families & Communities LLC increased its stake in shares of Danaher by 81.4% during the first quarter. Strengthening Families & Communities LLC now owns 254 shares of the conglomerate’s stock valued at $52,000 after buying an additional 114 shares during the period. Finally, Saudi Central Bank bought a new position in shares of Danaher during the first quarter valued at approximately $52,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Wall Street Analysts Forecast Growth
Several analysts recently weighed in on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a report on Wednesday, October 8th. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Redburn Partners set a $220.00 price target on shares of Danaher in a research note on Wednesday, October 8th. JPMorgan Chase & Co. raised their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a report on Wednesday, October 22nd. Finally, TD Cowen upped their target price on Danaher from $250.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Twenty equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $245.75.
Insiders Place Their Bets
In related news, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the transaction, the senior vice president owned 2,625 shares in the company, valued at $552,352.50. The trade was a 66.34% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the sale, the senior vice president directly owned 14,553 shares in the company, valued at $3,190,454.19. This trade represents a 59.94% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 30,248 shares of company stock valued at $6,609,663. 11.10% of the stock is currently owned by corporate insiders.
Danaher Trading Down 0.4%
Shares of NYSE DHR opened at $226.20 on Friday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The firm has a 50-day moving average of $216.22 and a 200 day moving average of $204.36. The stock has a market cap of $159.78 billion, a P/E ratio of 46.64, a price-to-earnings-growth ratio of 4.39 and a beta of 0.89.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The business had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same quarter last year, the firm earned $1.71 earnings per share. The business’s revenue for the quarter was up 4.4% on a year-over-year basis. As a group, sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.
Danaher Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Shareholders of record on Friday, September 26th were paid a dividend of $0.32 per share. The ex-dividend date was Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s payout ratio is presently 26.39%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Ulta’s Stock May Be Set for a Glow-Up—20% Upside Ahead?
- Insider Buying Explained: What Investors Need to Know
- Gates Foundation Sells MSFT Stock—Should Investors Be Worried?
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 12/1 – 12/5
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
